阻断血细胞命运可以增强B细胞的抗原特异性呈现,以增强抗瘤免疫力
Yunqiao Li1, Raag Bhargava1, Jenny Tuyet Tran1
1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Nature communications
|May 13, 2025
概括
抑制B细胞中的血细胞分化通过促进抗原呈现和T细胞激活来增强抗瘤免疫力. 这一发现表明了癌症治疗的新型免疫疗法方法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 众所周知,B细胞参与抗瘤免疫,但它们在抑制癌症中的确切作用尚未完全理解.
- 血细胞分化是B细胞的一个关键功能,涉及抗体分泌.
研究的目的:
- 研究抑制血细胞分化对抗瘤免疫力的影响.
- 探索针对B细胞分化作为癌症免疫治疗策略的潜力.
主要方法:
- 使用IgMi小鼠 (缺乏抗体分泌) 和B细胞特异性淘汰Blimp-1 (Blimp-1 BcKO) 小鼠.
- 分析了Blimp-1缺乏瘤透B细胞的转录特征.
- 评估了主要基因相容性复合物II类 (MHC II) 和共刺激分子 (CD80,CD86) 在抗瘤疗效中的作用.
- 给了Blimp-1抑制剂瓦尔酸,以评估其对瘤生长的影响.
主要成果:
- 抑制血细胞分化促进了抗瘤免疫力,并增加了活性B细胞数量.
- 在B细胞中的Blimp-1缺陷导致了独特的转录变化,包括扩展的突变克隆向瘤细胞.
- 在Blimp-1缺乏B细胞上增加CD80和CD86的表达,增强了T细胞功能的作用.
- 瓦尔酸以B细胞依赖的方式抑制了瘤生长.
结论:
- 抑制血细胞分化增强了B细胞的瘤特异性抗原呈现,导致瘤抑制.
- 在B细胞中Blimp-1缺陷通过改善抗原呈现和T细胞激活促进抗瘤免疫力.
- 向血细胞分化是癌症的有希望的免疫疗法策略.
更多相关视频
10:26In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
12.0K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
相关概念视频
B Cell Activation and Differentiation
1.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.3K
T Cell Activation and Clonal Selection
609
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
609
Cytotoxic T Cells-mediated Immune Response
812
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
812
Tumor Immunotherapy
441
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
441
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cell-mediated Immune Responses
66.5K
Overview
66.5K
